From: Non -fatal overdose among people who inject drugs in Tehran, Iran
Characteristics | Over dose | P-Value | |
---|---|---|---|
AOR | (% CI95) | ||
Age (year) | |||
< 30 | 1 | .......... | – |
30–39 | 1.3 | (0.1–5.3) | 0.3 |
40+ | 1.4 | (0.2–4.8) | |
Education | |||
> High school | 1 | .......... | – |
< High school | 1.3 | (0.8–2.31) | 0.4 |
Income (USD) | |||
> 150 | 1 | .......... | – |
< 150 | 1.65 | (0.93–2.99) | 0.3 |
Age of drug initiation (year) | |||
< 20 | 2.2 | (1.8–5.7) | 0.01 |
20+ | 1 | – | – |
Duration of inject drug | |||
< 2 | 2.7 | (1.6–4.61) | 0.02 |
> 2 | 1 | .......... | – |
Methamphetamine use | |||
Yes | 2.8 | (1.8–7.4) | 0.02 |
No | 1 | .......... | – |
Poly Drug | |||
Yes | 2.1 | (1.4–5.3) | |
No | 1 | .......... | 0.01 |
Alcohol use | |||
Yes | 2.8 | (1.2–4.3) | 0.01 |
No | 1 | .......... | – |
Needle and syringe Program exposure | |||
Regular use of NSP | 0.6 | (0.2–0.9) | 0.01 |
Irregular use of NSP | 1 | – | – |